Details for Patent: 11,672,938
✉ Email this page to a colleague
Which drugs does patent 11,672,938 protect, and when does it expire?
Patent 11,672,938 protects GENOSYL and is included in one NDA.
Summary for Patent: 11,672,938
Title: | Start-up protocols for nitric oxide delivery device |
Abstract: | Start-up protocols for a device and method for administering NO is described. |
Inventor(s): | David H. Fine, Edward Bromberg, Ryan Denton, Jason White, Lucas G. Gamero, Bryan Johnson, Gregory Vasquez, Doug Sonosky |
Assignee: | Vero Biotech Inc |
Application Number: | US16/513,312 |
Patent Claim Types: see list of patent claims | More… ↓ |
Drugs Protected by US Patent 11,672,938
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 11,672,938 | ⤷ Subscribe | A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |